Amelioration of hyperoxia-induced lung injury using a sphingolipid-based intervention

European Respiratory Journal

Volumn 42, Issue 3, 2013, Pages 776-784

  Tibboel, Jeroen ^a,c   Joza, Stephen ^a,b   Reiss, Irwin ^c   De Jongste, Johan C ^c   Post, Martin ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; OXYGEN; SPHINGOLIPID; SPHINGOSINE;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HYPEROXIA; LUNG ALVEOLUS; LUNG FUNCTION; LUNG INJURY; LUNG INSUFFICIENCY; LUNG LAVAGE; LUNG VOLUME; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOPULMONARY DYSPLASIA; CERAMIDES; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; HYPEROXIA; LUNG; LUNG INJURY; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; OXYGEN INHALATION THERAPY; SPHINGOLIPIDS; SPHINGOSINE; VITAL CAPACITY;

EID: 84883517691     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00092212     Document Type: Article

References (35)

1. Abman SH, Mourani PM, Sontag M. Bronchopulmonary dysplasia: a genetic disease. Pediatrics 2008; 122: 658-659.
2. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999; 46: 641-643.
3. Hannun YA, Obeid LM. Many ceramides. J Biol Chem 2011; 286: 27855-27862.
4. Gulbins E, Li PL. Physiological and pathophysiological aspects of ceramide. Am J Physiol Regul Integr Comp Physiol 2006; 290: R11-R26.
5. Ammit AJ, Hastie AT, Edsall LC, et al. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J 2001; 15: 1212-1214.
6. Lahiri S, Futerman AH. The metabolism and function of sphingolipids and glycosphingolipids. Cell Mol Life Sci 2007; 64: 2270-2284. (Pubitemid 47347954)
7. Payne SG, Milstien S, Spiegel S. Sphingosine-1-phosphate: dual messenger functions. FEBS Lett 2002; 531: 54-57. (Pubitemid 35232784)
8. May M, Ströbel P, Preisshofen T, et al. Apoptosis and proliferation in lungs of ventilated and oxygen-treated preterm infants. Eur Respir J 2004; 23: 113-121. (Pubitemid 38088507)
9. Dieperink HI, Blackwell TS, Prince LS. Hyperoxia and apoptosis in developing mouse lung mesenchyme. Pediatr Res 2006; 59: 185-190. (Pubitemid 43840986)
10. Husari AW, Dbaibo GS, Bitar H, et al. Apoptosis and the activity of ceramide, Bax and Bcl-2 in the lungs of neonatal rats exposed to limited and prolonged hyperoxia. Respir Res 2006; 7: 100.
11. Pappas CT, Obara H, Bensch KG, et al. Effect of prolonged exposure to 80% oxygen on the lung of the newborn mouse. Lab Invest 1983; 48: 735-748. (Pubitemid 13060029)
12. Yee M, White RJ, Awad HA, et al. Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice. Am J Pathol 2011; 178: 2601-2610.
13. Warner BB, Stuart LA, Papes RA, et al. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998; 275: L110-L117.
14. Tsuchida S, Engelberts D, Roth M, et al. Continuous positive airway pressure causes lung injury in a model of sepsis. Am J Physiol Lung Cell Mol Physiol 2005; 289: L554-L564. (Pubitemid 41361665)
15. Ridsdale R, Roth-Kleiner M, D'Ovidio F, et al. Surfactant palmitoylmyristoylphosphatidylcholine is a marker for alveolar size during disease. Am J Respir Crit Care Med 2005; 172: 225-232. (Pubitemid 40981198)
16. Velten M, Heyob KM, Rogers LK, et al. Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure. J Appl Physiol 2010; 108: 1347-1356.
17. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007; 357: 1946-1955. (Pubitemid 350074689)
18. Aquino SL, Schechter MS, Chiles C, et al. High-resolution inspiratory and expiratory CT in older children and adults with bronchopulmonary dysplasia. AJR Am J Roentgenol 1999; 173: 963-967. (Pubitemid 29451294)
19. Wong PM, Lees AN, Louw J, et al. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J 2008; 32: 321-328.
20. May C, Kennedy C, Milner AD, et al. Lung function abnormalities in infants developing bronchopulmonary dysplasia. Arch Dis Child 2011; 96: 1014-1019.
21. Robin B, Kim Y-J, Huth J, et al. Pulmonary function in bronchopulmonary dysplasia. Pediatr Pulmonol 2004; 37: 236-242. (Pubitemid 38326373)
22. Park JY, Kim MJ, Kim YK, et al. Ceramide induces apoptosis via caspase-dependent and caspase-independent pathways in mesenchymal stem cells derived from human adipose tissue. Arch Toxicol 2011; 85: 1057-1065.
23. Dechecchi MC, Nicolis E, Mazzi P, et al. Modulators of sphingolipid metabolism reduce lung inflammation. Am J Respir Cell Mol Biol 2011; 45: 825-833.
24. Kolliputi N, Galam L, Parthasarathy PT, et al. NALP-3 inflammasome silencing attenuates ceramide-induced transepithelial permeability. J Cell Physiol 2012; 227: 3310-3316.
25. Mathias S, Peña LA, Kolesnick RN. Signal transduction of stress via ceramide. Biochem J 1998; 335: 465-480. (Pubitemid 28515396)
26. Hartmann D, Lucks J, Fuchs S, et al. Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth. Int J Biochem Cell Biol 2012; 44: 620-628.
27. Mesicek J, Lee H, Feldman T, et al. Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell Signal 2010; 22: 1300-1307.
28. Xu D, Perez RE, Ekekezie II, et al. Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death. Am J Physiol Lung Cell Mol Physiol 2008; 294: L17-L23. (Pubitemid 351380314)
29. Franco-Montoya M-L, Bourbon JR, Durrmeyer X, et al. Pulmonary effects of keratinocyte growth factor in newborn rats exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 2009; 297: L965-L976.
30. Alejandre-Alcázar MA, Kwapiszewska G, Reiss I, et al. Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007; 292: L537-L549.
31. Hargitai B, Szabó V, Hajdú J, et al. Apoptosis in various organs of preterm infants: histopathologic study of lung, kidney, liver, and brain of ventilated infants. Pediatr Res 2001; 50: 110-114. (Pubitemid 32566581)
32. de Visser YP, Walther FJ, Laghmani EH, et al. Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats. Am J Physiol Lung Cell Mol Physiol 2012; 302: L56-L67.
33. Schweitzer KS, Hatoum H, Brown MB, et al. Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides. Am J Physiol Lung Cell Mol Physiol 2011; 301: L836-L846.
34. Göggel R, Winoto-Morbach S, Vielhaber G, et al. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. Nat Med 2004; 10: 155-160. (Pubitemid 38524885)
35. Diab KJ, Adamowicz JJ, Kamocki K, et al. Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema. Am J Respir Crit Care Med 2010; 181: 344-352.